Sanders Corazon (Corsee) D.
SEC insider (Form 3/4/5 filer). CIK 0001796536. Director at Legend Biotech Corp (LEGN) and 4 other issuers. 15 reported Form 4/5 transactions since Sep 2024; latest on Sep 29, 2026. Located in BRIDGEWATER, NJ.
Companies Sanders Corazon (Corsee) D. has filed insider reports for
- Legend Biotech Corp (LEGN): Director
- Calidi Biotherapeutics, Inc. (CLDI): Director
- Ultragenyx Pharmaceutical Inc. (RARE): Director
- BeOne Medicines Ltd. (ONC): Director
- Molecular Templates, Inc. (MTEM): Director
Sanders Corazon (Corsee) D.
CIK: 0001796536
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Sep 29, 2026LEGN
Legend Biotech Corp
SaleDirect27.4K shares at avg. $9.46$259K - Sep 24, 2026LEGN
Legend Biotech Corp
AwardDirect21K shares- - Aug 17, 2026CLDI
Calidi Biotherapeutics, Inc.
AwardDirectNon-Qualified Stock Options (right to buy)
6K shares- - Jun 15, 2026RARE
Ultragenyx Pharmaceutical Inc.
SaleDirect2K shares at avg. $25.05$50K - May 22, 2026ONC
BeOne Medicines Ltd.
SaleDirect212 shares at avg. $309.59$66K - May 14, 2026RARE
Ultragenyx Pharmaceutical Inc.
AwardDirect7.8K shares- - Nov 26, 2025ONC
BeOne Medicines Ltd.
ExerciseDirect2.6K shares at avg. $159.03$418K - Nov 26, 2025ONC
BeOne Medicines Ltd.
SaleDirect1.8K shares at avg. $340.20$620K - Nov 26, 2025ONC
BeOne Medicines Ltd.
SaleDirect804 shares at avg. $342.47$275K - Sep 5, 2025ONC
BeOne Medicines Ltd.
SaleDirect2.7K shares at avg. $337.00$898K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 29, 2026 | LEGN Legend Biotech Corp | Sale | 27,370 | $9.46 | $258,920 | Direct |
| Sep 24, 2026 | LEGN Legend Biotech Corp | Award | 20,986 | - | $0 | Direct |
| Aug 17, 2026 | CLDI Calidi Biotherapeutics, Inc. | Award Non-Qualified Stock Options (right to buy) | 6,000 | - | - | Direct |
| Jun 15, 2026 | RARE Ultragenyx Pharmaceutical Inc. | Sale | 2,000 | $25.05 | $50,100 | Direct |
| May 22, 2026 | ONC BeOne Medicines Ltd. | Sale | 212 | $309.59 | $65,633 | Direct |
| May 14, 2026 | RARE Ultragenyx Pharmaceutical Inc. | Award | 7,751 | - | $0 | Direct |
| Nov 26, 2025 | ONC BeOne Medicines Ltd. | Exercise | 2,627 | $159.03 | $417,772 | Direct |
| Nov 26, 2025 | ONC BeOne Medicines Ltd. | Sale | 1,823 | $340.20 | $620,185 | Direct |
| Nov 26, 2025 | ONC BeOne Medicines Ltd. | Sale | 804 | $342.47 | $275,349 | Direct |
| Sep 5, 2025 | ONC BeOne Medicines Ltd. | Sale | 2,665 | $337.00 | $898,105 | Direct |
1-10 of 15 transactions